Skba Capital Management LLC Novo Nordisk A S Transaction History

Skba Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$41.54 - $47.25 $266,271 - $302,872	-6,410 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $9.91 Million - $10.9 Million	-211,850 Reduced 97.06%	6,410 $302,000
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $163,873 - $186,554	-3,700 Reduced 1.67%	218,260 $10.1 Million
Q1 2018 May 08, 2018	SELL	$48.49 - $58.14 $2.49 Million - $2.98 Million	-51,300 Reduced 18.77%	221,960 $10.9 Million
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $204,379 - $231,039	-4,300 Reduced 1.55%	273,260 $14.7 Million
Q3 2017 Nov 08, 2017	BUY	$41.15 - $49.22 $11.4 Million - $13.7 Million	277,560	277,560 $13.4 Million

1,956

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $239B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Skba Capital Management LLC with notifications on news.